Gene Expression Profiling in Diethylnitrosamine Treated Mouse Liver: From Pathological Data to Microarray Analysis
2007
Kim, J.Y. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea) | Yoon, S.J. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea) | Park, H.J. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea) | Kim, Y.B. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea) | Cho, J.W. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea) | Koh, W.S. (Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea) | Lee, M.C.E. (University of Incheon, Incheon, Republic of Korea), E-mail: [email protected]
Diethylnitrosamine (DEN) is a nitrosamine compound that can induce a variety of liver lesions including hepatic carcinoma, forming DNA-carcinogen adducts. In the present study, microarray analyses were performed with Affymetrix Murine Genome 430A Array in order to identify the gene-expression profiles for DEN and to provide valuable information for the evaluation of potential hepatotoxicity. C57BL/6NCrj mice were orally administered once with DEN at doses of 0, 3, 7 and 20 ㎎/㎏. Liver from each animal was removed 2, 4, 8 and 24 hrs after the administration. The histopathological analysis and serum biochemical analysis showed no significant difference in DEN-treated groups compared to control group. Conversely, the principal component analysis (PCA) profiles demonstrated that a specific normal gene expression profile in control groups differed clearly from the expression profiles of DEN-treated groups. Within groups, a little variance was found between individuals. Student’s t-test on the results obtained from triplicate hybridizations was performed to identify those genes with statistically significant changes in the expression. Statistical analysis revealed that 11 genes were significantly downregulated and 28 genes were upregulated in all three animals after 2 h treatment at 20 ㎎/㎏. The upregulated group included genes encoding Gdf15, JunD1, and Mdm2, while the genes including Sox6, Shmt2, and Slc6a6 were largely down regulated. Hierarchical clustering of gene expression also allowed the identification of functionally related clusters that encode proteins related to metabolism, and MAPK signaling pathway. Taken together, this study suggests that match with a toxicant signature can assign a putative mechanism of action to the test compound if is established a database containing response patterns to various toxic compounds.
显示更多 [+] 显示较少 [-]